[Form 4] RB GLOBAL INC. Insider Trading Activity
Rhea-AI Filing Summary
Michael D. Sieger, a director of RB Global Inc. (ticker: RBA), reported on Form 4 that on 09/18/2025 he acquired dividend equivalent rights tied to deferred share units and to a 2025 restricted share unit (RSU) grant. The filing records an acquisition of 6 dividend equivalent rights related to deferred share units and 5 dividend equivalent rights related to 2025 RSUs; each right represents a contingent entitlement to the economic equivalent of one RBA common share and were acquired at a price of $0. The reported ownership form for both items is direct. The form shows 52 and 10 derivative securities beneficially owned following the respective transactions. The filing was signed by an attorney-in-fact on behalf of Mr. Sieger on 09/19/2025.
Positive
- Acquisition of 11 dividend equivalent rights (6 and 5) indicating continued alignment of director compensation with shareholder value
- No cash outlay for the acquired dividend equivalent rights (price reported as $0), reflecting compensation issuance rather than market purchases
Negative
- None.
Insights
TL;DR: Routine executive compensation accruals; no cash consideration and limited share equivalents, so minimal immediate dilution.
The Form 4 documents non-cash acquisitions of dividend equivalent rights tied to deferred share units and RSUs, totaling 11 contingent share equivalents acquired on 09/18/2025. These awards are compensation-related and become payable in line with the underlying deferred units and RSUs, which limits immediate market impact. Reported post-transaction beneficial holdings of 52 and 10 derivative securities suggest modest insider exposure but do not indicate disposition or cash proceeds. For governance assessment, this is a standard disclosure of director compensation rather than material corporate action.
TL;DR: Compliance filing records acquisition of contingent dividend equivalents; appears routine and consistent with Rule 16 reporting.
The filing clearly states the transaction codes as acquisitions at a price of $0, and includes the required explanatory footnotes about the timing and linkage of dividend equivalent rights to deferred share units and 2025 RSUs. The form is signed by an attorney-in-fact, with filing dates provided. There are no sales, exercised options, or transfers reported here, so the disclosure meets Section 16 reporting requirements without indicating unusual insider trading activity.